JASON WHITE: Open Payments
NPI 1700211828 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 68 payments from 20 companies in 2025. Trend: 2023 $2,300 · 2024 $2,526 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $525 |
| Teva Pharmaceuticals USA, Inc. | 8 | $161 |
| Axsome Therapeutics, Inc. | 7 | $136 |
| MicroTransponder, Inc. | 1 | $112 |
| Amneal Pharmaceuticals LLC | 3 | $59 |
| Boston Scientific Corporation | 1 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| JAZZ PHARMACEUTICALS INC. | 2 | $55 |
| ACADIA Pharmaceuticals Inc | 2 | $55 |
| UCB, Inc. | 2 | $45 |
Products named: UBRELVY, QULIPTA, Symbravo, AJOVY, BOTOX, WATCHMAN FLX, INGREZZA, EPIDIOLEX.
Industry payments across IN — which companies pay providers there.
